newsfilter
← Latest News
ACCESS Newswire·

Biophytis Announces Filing of an IND Application with the US FDA for its Phase 2 Study in Obesity

PARIS, FRANCE and CAMBRIDGE, MA / ACCESSWIRE / June 10, 2024 / Biophytis SA , , a clinical-stage biotechnology company specialized in the development of